Scientists have cloned a genetically engineered bull which they hope will help heart valve transplant patients lead better quality lives and benefit people with red meat allergies.
SAPHIRe – Securing the adoption of personalised health in regions – is a three year project (2019-2021) funded by the European Commission (DG Research and Innovation) under the Horizon 2020 programme and is managed by a consortium consisting of the department of Economy, Science and Innovation of the Flemish Government, the Public Health Agency of Northern Ireland and EIT. The aim of the project is to map personalised medicine and health policies in European regions and to establish and support networking between interested regions in order to facilitate interregional collaboration and identify opportunities for funding of joint projects.
In 2017, over 30 000 patients in the European Union (EU) received healthy blood-forming cells (stem cells) to replace their own that had been destroyed. The highest numbers of stem cell transplants were reported in Germany (7 700), France (5 500), Italy (5 100), the United Kingdom (3 800) and Spain (3 100; 2015 data).